Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 625.00 | 270.29 | 764.67 | 765.92 | 0.9985 | 0.9963 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 625.00 | 270.29 | 765.67 | 765.92 | 1.0014 | 1.0039 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 625.00 | 270.29 | 791.67 | 765.92 | 1.0334 | 1.0436 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 625.00 | 270.29 | 916.33 | 765.92 | 1.1953 | 1.2516 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 625.00 | 270.29 | 787.67 | 765.92 | 1.0321 | 1.0463 |
| BT-20 | Erlotinib | 1 | uM | 7 | 625.00 | 270.29 | 723.67 | 765.92 | 0.9493 | 0.9343 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 625.00 | 270.29 | 718.33 | 765.92 | 0.9387 | 0.9175 |
| BT-20 | Erlotinib | 10 | uM | 7 | 625.00 | 270.29 | 550.33 | 765.92 | 0.7206 | 0.6076 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 625.00 | 270.29 | 587.67 | 765.92 | 0.7785 | 0.6923 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 1250.00 | 580.08 | 1877.33 | 1837.58 | 1.0224 | 1.0271 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 1250.00 | 580.08 | 1840.33 | 1837.58 | 1.0037 | 1.0044 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 1250.00 | 580.08 | 1914.00 | 1837.58 | 1.0432 | 1.0519 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 1250.00 | 580.08 | 1985.33 | 1837.58 | 1.0805 | 1.0954 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 1250.00 | 580.08 | 1808.00 | 1837.58 | 0.9843 | 0.9813 |
| BT-20 | Erlotinib | 1 | uM | 7 | 1250.00 | 580.08 | 1785.00 | 1837.58 | 0.9705 | 0.9630 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 1250.00 | 580.08 | 1626.67 | 1837.58 | 0.8867 | 0.8600 |
| BT-20 | Erlotinib | 10 | uM | 7 | 1250.00 | 580.08 | 1275.67 | 1837.58 | 0.6957 | 0.6076 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 1250.00 | 580.08 | 1336.67 | 1837.58 | 0.7295 | 0.6518 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 4434.33 | 4280.58 | 1.0356 | 1.0408 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 2500.00 | 1312.79 | 4359.00 | 4280.58 | 1.0184 | 1.0214 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 4213.33 | 4280.58 | 0.9846 | 0.9818 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 2500.00 | 1312.79 | 4229.67 | 4280.58 | 0.9887 | 0.9869 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 3910.00 | 4280.58 | 0.9118 | 0.8917 |
| BT-20 | Erlotinib | 1 | uM | 7 | 2500.00 | 1312.79 | 3599.00 | 4280.58 | 0.8405 | 0.8056 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 3446.33 | 4280.58 | 0.8052 | 0.7613 |